Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3 Receptor Ligands:  Inhibition of Cocaine-Seeking Behavior and the Role of Dopamine D3/D2 Receptors

• Published in: Journal of medicinal chemistry Vol. 46; no. 18; pp. 3822 - 3839
• Main Authors: Campiani, Giuseppe, Butini, Stefania, Trotta, Francesco, Fattorusso, Caterina, Catalanotti, Bruno, Aiello, Francesca, Gemma, Sandra, Nacci, Vito, Novellino, Ettore, Stark, Jennifer Ann, Cagnotto, Alfredo, Fumagalli, Elena, Carnovali, Francesco, Cervo, Luigi, Mennini, Tiziana
• Format: Journal Article
• Language: English
• Published: Washington, DC American Chemical Society 28.08.2003
• Subjects: Animals; Behavior, Addictive - drug therapy; Behavior, Addictive - psychology; Biological and medical sciences; Brain - metabolism; Catecholaminergic system; Cocaine - administration & dosage; Cocaine-Related Disorders - psychology; Conditioning, Operant - drug effects; Dopamine Agonists - chemical synthesis; Dopamine Agonists - chemistry; Dopamine Agonists - pharmacology; Dopamine Antagonists - chemical synthesis; Dopamine Antagonists - chemistry; Dopamine Antagonists - pharmacology; Drug addictions; Extinction, Psychological - drug effects; In Vitro Techniques; Ligands; Male; Medical sciences; Models, Molecular; Neuropharmacology; Neurotransmitters. Neurotransmission. Receptors; Pharmacology. Drug treatments; Piperazines - chemical synthesis; Piperazines - chemistry; Piperazines - pharmacology; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 - drug effects; Receptors, Dopamine D2 - physiology; Receptors, Dopamine D3; Self Administration; Structure-Activity Relationship; Toxicology; Partial agonist; Replacement therapy; Intravenous administration; Central nervous system; Benzene derivatives; Selectivity; Searching behavior; In vitro; Modeling; D3 Dopamine receptor; In vivo; Structure activity relation; Chlorine Organic compounds; Animal; Molecular model; Affinity; Cocaine; Drug of abuse; Antagonist; Piperazine derivatives; Chemical synthesis; Brain (vertebrata)
• ISSN: 0022-2623; 1520-4804
• DOI: 10.1021/jm0211220

The synthesis, pharmacological evaluation, and structure−activity relationships (SARs) of a series of novel arylalkylpiperazines structurally related to BP897 (3) are described. In binding studies, the new derivatives were tested against a panel of dopamine, serotonin, and noradrenaline receptor subtypes. Focusing mainly on dopamine D3 receptors, SAR studies brought to light a number of structural features required for high receptor affinity and selectivity. Several heteroaromatic systems were explored for their dopamine receptor affinities, and combinations of synthesis, biology, and molecular modeling, were used to identify novel structural leads for the development of potent and selective D3 receptor ligands. Introduction of an indole ring linked to a dichlorophenylpiperazine system provided two of the most potent and selective ligands known to date (D3 receptor affinity in the picomolar range). The intrinsic pharmacological properties of a subset of potent D3 receptor ligands were also assessed in [35S]-GTPγS binding assays. Evidence from animal studies, in particular, has highlighted the dopaminergic system's role in how environmental stimuli induce drug-seeking behavior. We therefore tested two novel D3 receptor partial agonists and a potent D3-selective antagonist in vivo for their effect in the cocaine-seeking behavior induced by reintroduction of cocaine-associated stimuli after a long period of abstinence, and without any further cocaine. Compound 5g, a nonselective partial D3 receptor agonist with a pharmacological profile similar to 3, and 5p, a potent and selective D3 antagonist, reduced the number of active lever presses induced by reintroduction of cocaine-associated stimuli. However, 5q, a highly potent and selective D3 partial agonist, did not have any effect on cocaine-seeking behavior. Although brain uptake studies are needed to establish whether the compounds achieve brain concentrations comparable to those active in vitro on the D3 receptor, our experiments suggest that antagonism at D2 receptors might significantly contribute to the reduction of cocaine craving by partial D3 agonists.